AI tool aims to end guesswork in depression treatment
NCT ID NCT06550037
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting data from 350 people with major depression to build an AI tool that helps doctors choose the best antidepressant for each patient. Researchers are analyzing blood, gut bacteria, brain activity, and genetics to find patterns that predict treatment success. The goal is to make depression care more personalized and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Università Degli Studi Di Siena
Siena, 53100, Italy